These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 28409839)
21. Experiences with learning and confirming in drug and biological development. Patterson SD Clin Pharmacol Ther; 2010 Aug; 88(2):161-3. PubMed ID: 20648033 [TBL] [Abstract][Full Text] [Related]
22. Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development. Dingemanse J; Krause A Eur J Pharm Sci; 2017 Nov; 109S():S53-S58. PubMed ID: 28535992 [TBL] [Abstract][Full Text] [Related]
23. A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development. Bai JPF; Earp JC; Strauss DG; Zhu H CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):675-677. PubMed ID: 33159491 [No Abstract] [Full Text] [Related]
29. Symposium on 'challenges in clinical pharmacology.'. Singhal MK Indian J Exp Biol; 2002 Feb; 40(2):237-8. PubMed ID: 12622193 [No Abstract] [Full Text] [Related]
30. Advancing pharmacometrics and systems pharmacology. Waldman SA; Terzic A Clin Pharmacol Ther; 2012 Nov; 92(5):535-7. PubMed ID: 23085873 [TBL] [Abstract][Full Text] [Related]
31. Multiscale modeling in drug discovery and development: future opportunities and present challenges. Vicini P Clin Pharmacol Ther; 2010 Jul; 88(1):126-9. PubMed ID: 20520608 [TBL] [Abstract][Full Text] [Related]
32. The extinction of drugs for clinical research: Can the ECNP medicines chest save them? Nutt D; Kilpatrick G; Hayes A Eur Neuropsychopharmacol; 2014 Apr; 24(4):487-90. PubMed ID: 24508534 [No Abstract] [Full Text] [Related]
33. Journal Impact Factor: it will go away soon. Diamandis EP Clin Chem Lab Med; 2009; 47(11):1317-8. PubMed ID: 19778288 [No Abstract] [Full Text] [Related]
34. The Journal of Visceral Surgery has doubled its impact factor in just two years! Mariette C J Visc Surg; 2013 Sep; 150(4):227-8. PubMed ID: 23969219 [No Abstract] [Full Text] [Related]
35. Quantitative Systems Pharmacology: A Case for Disease Models. Musante CJ; Ramanujan S; Schmidt BJ; Ghobrial OG; Lu J; Heatherington AC Clin Pharmacol Ther; 2017 Jan; 101(1):24-27. PubMed ID: 27709613 [TBL] [Abstract][Full Text] [Related]
36. ASCPT Task Force for advancing pharmacometrics and integration into drug development. Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032 [TBL] [Abstract][Full Text] [Related]
37. The Journal of Psychosomatic Research: the state of the journal in 2013. Leentjens AF; Levenson JL J Psychosom Res; 2013 Jan; 74(1):1. PubMed ID: 23272979 [No Abstract] [Full Text] [Related]
39. Benefit and risk assessment in drug development and utilization: a role for clinical pharmacology. Honig P Clin Pharmacol Ther; 2007 Aug; 82(2):109-12. PubMed ID: 17632530 [No Abstract] [Full Text] [Related]
40. Ophthalmology journals and the ether: considering Journal Impact Factor and citation analysis in context. Cartwright VA; Savino PJ Clin Exp Ophthalmol; 2009 Dec; 37(9):833-5. PubMed ID: 20092590 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]